FindTrial
Sign In

TO ASSESS EFFICACY OF ERANDA KSHAR YOGA AND TRYUSHNADI GUGGULU IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA

A COMPARATIVE STUDY ON THE EFFECT OF ERANDA KSHAR YOGA AND TRYUSHNADI GUGGULU IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032552
Enrollment
60
Registered
2021-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Group A - Tryushnadi guggulu: 500 mg BD orally with lukewarm water Intervention2: Group B -Eranda kshar yoga: eranda kshar 250 mg + hingu churna 250 mg as prakshep with manda Interventi

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients between the age group of 18-60 years of either sex. b) Willing and able to participate in the study for 90 days. c) Patients having Serum Cholesterol 201-400mg/dl, Serum Triglycerides 151- 400 mg/dl LDL Cholesterol 131-250 mg/dl, HDL Cholesterol d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%)

Exclusion criteria

Exclusion criteria: Patients having medical history of- a) Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure, Stroke or severe Arrhythmia, Unstable angina in the last six months. b) Patients on prolonged ( >6weeks) medication with corticosteroids, antidepressants, anticholinergics, immunosuppressant, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study and patients on oral contraceptives. c) Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents. d) Patients with evidence of malignancy. e) Hypersensitivity to any of the trial drugs or their ingredients. f) Patients who have completed participation in any other clinical trial drugs or their ingredients in one -month period. g) Patients who have received any cholesterol lowering medication (allopathic drug) within last two weeks. h) Pregnancy and Lactating mother.

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical efficacy of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.Timepoint: 3 Months—

Secondary

MeasureTime frame
To evaluate the safety of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.Timepoint: 90 Days—

Countries

India

Contacts

Public ContactDrSujata Yadav

Ayurvedic & Unani Tibbia College Karol Bagh New Delhi -110005

Sujatakcdelhi@gmail.com9354925030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026